Avoro Capital Advisors LLC United Therapeutics Corp Transaction History

Avoro Capital Advisors LLC

$7.32 Billion
Q3 2025

A detailed history of Avoro Capital Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,022,222 shares of UTHR stock, worth $943 Million. This represents 11.58% of its overall portfolio holdings.

Number of Shares

2,022,222

Previous 2,370,000 14.67%

Holding current value

$943 Million

Previous $681 Million 24.48%

% of portfolio

11.58%

Previous 12.42%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$274.7 - $438.75 $95.5 Million - $153 Million	-347,778 Reduced 14.67%	2,022,222 $848 Million
Q2 2025 Aug 14, 2025	SELL	$276.47 - $328.4 $84.3 Million - $100 Million	-305,000 Reduced 11.4%	2,370,000 $681 Million
Q1 2025 May 15, 2025	SELL	$304.42 - $380.78 $26 Million - $32.5 Million	-85,300 Reduced 3.09%	2,675,000 $825 Million
Q4 2024 Feb 14, 2025	SELL	$348.66 - $410.0 $34.4 Million - $40.4 Million	-98,588 Reduced 3.45%	2,760,300 $974 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $1.37 Million - $1.64 Million	6,388 Added 0.22%	2,858,888 $629 Million

Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $12.2 Million - $14.3 Million	-57,499 Reduced 1.98%	2,852,500 $644 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $8.21 Million - $9.32 Million	39,999 Added 1.39%	2,909,999 $642 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $1.06 Million - $1.38 Million	5,000 Added 0.17%	2,870,000 $643 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $12.7 Million - $17.2 Million	-61,500 Reduced 2.1%	2,865,000 $797 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $8.84 Million - $10.6 Million	-43,500 Reduced 1.46%	2,926,500 $613 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $10.5 Million - $14.5 Million	-60,000 Reduced 1.98%	2,970,000 $700 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $830,800 - $1.07 Million	-5,000 Reduced 0.16%	3,030,000 $544 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $6.45 Million - $7.56 Million	35,000 Added 1.17%	3,035,000 $656 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $23.1 Million - $26.2 Million	150,000 Added 5.26%	3,000,000 $502 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $290 Million - $433 Million	2,850,000 New	2,850,000 $433 Million

Others Institutions Holding UTHR

# of Institutions

804

Shares Held

41.4M

Call Options Held

1.56M

Put Options Held

2.86M

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $21.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC United Therapeutics Corp Transaction History